Recall events
/
Event 95430
Event summary
Timeline bucket September 25, 2024
Product types Drug
Classifications Class III
Statuses Ongoing
Recalling firm wording Denison Pharmaceuticals, LLC
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
2 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 2
Adult Cough and Chest Congestion (Dextromethorphan HBr USP 20 mg, Guaifenesin USP 400mg), packaged in 4 oz bottles further package in cartons, Distributed by: Genexa Inc., Alanta, GA, 30318, NDC-69676-0077-9, UPC Code # 850015736155
D-0033-2025
Recall number D-0033-2025
Initiated September 25, 2024
Classification Class III
Status Ongoing
Quantity 72,648 bottles
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.
Code information Lot# 0104V, Exp 07/2025; 0106V, Exp 09/2024
Distribution pattern Product was distributed to two accounts that may have distributed the product further to the Retail Level.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[14770]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 2
Kids' Cough and Chest Congestion (Dextromethorphan HBr, USP 5mg/ Guaifenesin, USP 100 mg), packaged in 4 oz bottles further packaged in cartons, Distributed by: Genexa Inc., Alanta, GA, 30318, NDC-69676-0077-9, UPC Code# 850015736018
D-0034-2025
Recall number D-0034-2025
Initiated September 25, 2024
Classification Class III
Status Ongoing
Quantity 105,048 bottles
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.
Code information Lot#: 0813V, Exp 06/2025; 0103V, Exp 03/2025
Distribution pattern Product was distributed to two accounts that may have distributed the product further to the Retail Level.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[15796]
FDA event record
· Exact recall-number query on openFDA